Support the FDA standards recognition program for regenerative medicine therapies (SRP-RMT) by coordinating activities the enable the development of needed standards through engagement with…
Ended Awarded Last action
- Contract number
- 75F40124F80259
- Awardee
-
Nexight Group LLC UEI LBDVN6QLYPY4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $669,863
Award facts
- Contract value 32% obligated
-
- $669,863.00 Current, with exercised options
- $2,070,480.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $669,863 |
About this award
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Nexight Group LLC, a small business regulatory consulting firm based in Silver Spring, Maryland. The contract supports the FDA's Standards Recognition Program for Regenerative Medicine Therapies (SRP-RMT) by coordinating activities to enable the development of needed standards through engagement with regenerative medicine stakeholders. The contract has a ceiling value of $2,070,480.00 and a completion date of September 21, 2027. It is a firm fixed-price contract issued under the Multiple Award Schedule (MAS) contract vehicle. The contract does not have a set-aside designation.
Description
Support the FDA standards recognition program for regenerative medicine therapies (SRP-RMT) by coordinating activities the enable the development of needed standards through engagement with regenerative medicine stakeholders.
Quick answers
Who was awarded contract 75F40124F80259?
75F40124F80259 was awarded to Nexight Group LLC by Food and Drug Administration (Department of Health and Human Services) on August 22, 2024.
How much is contract 75F40124F80259 worth?
The government has obligated $669,863 on 75F40124F80259. Its potential value, with all options, is $2,070,480.
Is contract 75F40124F80259 an order under another contract?
Yes. 75F40124F80259 is a delivery order under GS10F176AA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40124F80259 competed?
The extent of competition for 75F40124F80259 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award